[Click e-Stock] "MEKICS Gains Momentum for US Entry Following Respiratory Therapy Device FDA Approval"

On March 24, independent research firm ValueFinder released an industry analysis report on respiratory therapy devices, stating, "With Korea entering a super-aged society, it is now time to take action."

By 2025, Korea's population aged 65 and over will account for 21.2% of the total population, marking its official entry into a super-aged society. Both the OECD and the UN have continuously raised warnings about Korea's rapid aging. Elderly individuals are more vulnerable to respiratory diseases due to declining lung function and weakened immunity, leading to a higher prevalence rate.

The report identified respiratory therapy devices as the core of treatment, forecasting that the global respiratory therapy device market will reach approximately 20 trillion won by 2034. Among global companies, ResMed was cited, while in the domestic market, MEKICS was highlighted as holding the leading market share in Korea.

MEKICS's HFT-750U respiratory therapy device obtained FDA approval in the United States last year, and ValueFinder noted the momentum generated by the company's full-scale entry into the US market.

Established in 1998, MEKICS is a medical device manufacturer specializing in respiratory therapy devices and patient monitors. It was listed on the KOSDAQ through a technology exception in 2015. Leveraging its long-standing experience, MEKICS has steadily expanded its market share by securing strong technological capabilities and references, exporting to 42 countries across seven continents, including Asia, the Middle East, and Europe. This year, with its entry into the North American market—which accounts for about 60% of the global ventilator market—significant performance turnaround is anticipated.

Jihoo, a researcher at ValueFinder, commented, "As the respiratory therapy process shifts from hospitals to homes, the rental market in Korea is expanding rapidly. In particular, demand for the treatment of snoring and sleep apnea is increasing quickly, and homecare-based rental services for CPAP machines are gaining attention. By providing customized services and therapeutic solutions through its own platform, MEKICS has been steadily expanding its market share."

Researcher Ji further noted, "While the United States is the largest market, accounting for 59% of the global total, there are still opportunities for market penetration, as there are only 20.5 ICU beds equipped with ventilators per 100,000 people. Furthermore, as of the third quarter last year, the combined value of tangible assets and investment real estate surpasses the company's current market capitalization, providing downside protection. The company’s performance in the US market will be the key determinant of its corporate value," he added.

This content was produced with the assistance of AI translation services.